Windlas Biotech Limited Stock

Equities

WINDLAS

INE0H5O01029

Pharmaceuticals

Market Closed - NSE India S.E. 07:40:31 2024-07-08 am EDT 5-day change 1st Jan Change
716.6 INR +0.25% Intraday chart for Windlas Biotech Limited -2.64% +67.15%
Sales 2022 4.66B 55.85M Sales 2023 5.13B 61.5M Capitalization 4.71B 56.51M
Net income 2022 381M 4.57M Net income 2023 426M 5.11M EV / Sales 2022 0.62 x
Net cash position 2022 1.69B 20.3M Net cash position 2023 1.27B 15.22M EV / Sales 2023 0.67 x
P/E ratio 2022
11.3 x
P/E ratio 2023
11.4 x
Employees -
Yield 2022
1.67%
Yield 2023
1.78%
Free-Float 37.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.25%
1 week-2.64%
Current month-0.14%
1 month+7.93%
3 months+32.39%
6 months+45.03%
Current year+67.15%
More quotes
1 week
708.00
Extreme 708
740.90
1 month
646.80
Extreme 646.8
794.50
Current year
452.55
Extreme 452.55
794.50
1 year
306.20
Extreme 306.2
794.50
3 years
203.25
Extreme 203.25
794.50
5 years
203.25
Extreme 203.25
794.50
10 years
203.25
Extreme 203.25
794.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15-10-15
Founder 73 00-12-31
Compliance Officer - 21-03-17
Members of the board TitleAgeSince
Chairman 57 21-05-05
Director/Board Member 47 21-05-03
Founder 73 00-12-31
More insiders
Date Price Change Volume
24-07-08 716.6 +0.25% 31,296
24-07-05 714.8 +0.58% 15,604
24-07-04 710.8 -1.39% 40,099
24-07-03 720.8 -2.47% 43,960
24-07-02 739 +0.40% 33,812

Delayed Quote NSE India S.E., July 08, 2024 at 07:40 am EDT

More quotes
Windlas Biotech Limited is an India-base domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The Company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (GMP). It develops and manufactures products to customers and consumers across India and some emerging markets, internationally. The Company specializes in manufacturing oral solids dosage and oral liquids dosage (OSD/OLD). It also extends to delivering specialty capabilities such as high potency, restricted chemicals, and low solubility products. Its product categories include pain management, gastro management, nutritional/food supplement, derma and hair care, respiratory management, diabetic management, cardiac management, neuro psychiatric management, tyro care, women healthcare and others.
More about the company
  1. Stock Market
  2. Equities
  3. WINDLAS Stock